Apo A1-LDL complex in coronary artery disease - Oxidized lipoprotein and inflammation

被引：0
|
作者：
Matsuno, S
Ogasawara, K
Mashiba, S
Hashimot, H
Uchida, K
Aizawa, T
机构：
[1] Cardiovasc Inst, Tokyo, Japan
[2] Teikyo Univ, Sch Med, Tokyo 173, Japan
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2006年 / 47卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：176A / 176A
页数：1
相关论文
共 50 条
  • [1] Oxidized LDL in unstable coronary artery disease
    Johnston, N
    Lagerqvist, B
    Siegbahn, A
    Wallentin, L
    CIRCULATION, 2002, 106 (19) : 75 - 75
  • [2] Impact of postprandial lipaemia on low-density lipoprotein (LDL) size and oxidized LDL in patients with coronary artery disease
    Graner, M.
    Kahri, J.
    Nakano, T.
    Sarna, S. J.
    Nieminen, M. S.
    Syvanne, M.
    Taskinen, M. R.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 (11) : 764 - 770
  • [3] Measurement of oxidized lipoprotein (a) in patients with acute coronary syndromes and stable coronary artery disease by 2 ELISAs: Using different capture antibody against oxidized lipoprotein (a) or oxidized LDL
    Wang, Jun-jun
    Han, Ai-zhong
    Meng, Yang
    Gong, Jian-bin
    Zhang, Chun-ni
    Li, Ke
    Liu, Yu-Xiu
    CLINICAL BIOCHEMISTRY, 2010, 43 (06) : 571 - 575
  • [4] Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease
    Tsimikas, S
    Brilakis, ES
    Miller, ER
    McConnell, JP
    Lennon, RJ
    Kornman, KS
    Witztum, JL
    Berger, PB
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (01): : 46 - 57
  • [5] Oxidized Low-Density Lipoprotein-β2-Glycoprotein I Complex But Not Free Oxidized LDL Is Associated With the Presence and Severity of Coronary Artery Disease
    Bliden, Kevin P.
    Chaudhary, Rahul
    Lopez, Luis R.
    Damrongwatanasuk, Rongras
    Guyer, Kirk
    Gesheff, Martin G.
    Franzese, Christopher J.
    Kaza, Himabindu
    Tantry, Udaya S.
    Gurbel, Paul A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 118 (05): : 673 - 678
  • [6] LOX-1 null mice lack endothelial response to oxidized LDL, and are resistant to inflammation and transplant coronary artery disease
    Sawamura, T
    Sanada, N
    Sakurai, K
    Suga, M
    Aoyama, T
    Sugawara, F
    Inoue, K
    Kakinuma, T
    Kawakami-Honda, N
    Hinagata, J
    Nakamura, K
    Masaki, T
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 61 - 61
  • [7] Lipoprotein(a), Oxidized Phospholipids, and Coronary Artery Disease Severity and Outcomes
    Gilliland, Thomas C.
    Liu, Yuxi
    Mohebi, Reza
    Miksenas, Hannah
    Haidermota, Sara
    Wong, Megan
    Hu, Xingdi
    Cristino, Joaquim
    Browne, Auris
    Plutzky, Jorge
    Tsimikas, Sam
    Januzzi, James L.
    Natarajan, Pradeep
    CIRCULATION, 2022, 146
  • [8] Lipoprotein(a), Oxidized Phospholipids, and Coronary Artery Disease Severity and Outcomes
    Gilliland, Thomas C.
    Liu, Yuxi
    Mohebi, Reza
    Miksenas, Hannah
    Haidermota, Sara
    Wong, Megan
    Hu, Xingdi
    Cristino, Joaquim Rosado
    Browne, Auris
    Plutzky, Jorge
    Tsimikas, Sotirios
    Januzzi Jr, James L.
    Natarajan, Pradeep
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (18) : 1780 - 1792
  • [9] Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease
    Holvoet, P
    Vanhaecke, J
    Janssens, S
    Van de Werf, F
    Collen, D
    CIRCULATION, 1998, 98 (15) : 1487 - 1494
  • [10] Circulating oxidized LDL and antibodies against oxidized LDL in type 2 diabetes patients with and without coronary artery disease
    Gelisgen, R.
    Cimen, B.
    Yumuk, V.
    Bolayirli, M.
    Hacibekiroglu, M.
    Burcak, G.
    FEBS JOURNAL, 2007, 274 : 265 - 265
12345